Clinical trial
Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and…
NCT00477945 · Indiana University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00477945 |
|---|---|
| Title | Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL |
| Official title | A Phase I Trial of Clofarabine in Combination With High-Dose Etoposide and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation for Patients With High-Risk or Refractory Non-Hodgkin's Lymphoma |
| Lead sponsor | Indiana University School of Medicine, Other |
| Collaborators | Genzyme, a Sanofi Company Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Non Hodgkin's Lymphoma |
| Intervention type | Drug |
| Interventions | clofarabine |
| Enrollment | 18 |
| Start date | May 1, 2007 |
| Primary completion | Nov 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | May 24, 2007 |
| Last update posted | Sep 11, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: